— Know what they know.
Not Investment Advice

ICUI NASDAQ

ICU Medical, Inc.
1W: -3.4% 1M: -6.2% 3M: -0.0% YTD: +15.1% 1Y: +31.8% 3Y: +36.2% 5Y: -34.4%
$159.38
+2.20 (+1.40%)
 
Weekly Expected Move ±3.9%
$147 $153 $159 $166 $172
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 43 · $4.0B mcap · 24M float · 1.20% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.2 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 2.7%  ·  5Y Avg: -0.9%
Cost Advantage ★
52
Intangibles
51
Switching Cost
22
Network Effect
23
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ICUI has No discernible competitive edge (39.2/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 2.7% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$187
Low
$196
Avg Target
$200
High
Based on 3 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 10Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$192.25
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-07 Needham Mike Matson $165 $187 +22 +1.0% $185.18
2026-08-07 BTIG — $170 $200 +30 +20.2% $166.37
2026-08-07 Raymond James Jayson Bedford $97 $200 +103 +20.2% $166.37
2026-07-21 KeyBanc Brett Fishbin $164 $182 +18 +15.7% $157.34
2026-06-15 BTIG — Initiated $170 — +19.5% $142.20
2026-05-27 Needham — Initiated $165 — +22.2% $134.97
2026-04-27 KeyBanc — $180 $164 -16 +31.4% $124.82
2026-04-17 Piper Sandler Jason Bednar $178 $163 -15 +29.3% $126.04
2026-02-20 Piper Sandler — $153 $178 +25 +18.9% $149.74
2026-02-20 KeyBanc Brett Fishbin $173 $180 +7 +20.2% $149.74
2025-10-21 KeyBanc Brett Fishbin $198 $173 -25 +47.4% $117.34
2025-09-10 Piper Sandler Jason Bednar $145 $153 +8 +15.3% $132.74
2025-08-15 Piper Sandler Jason Bednar Initiated $145 — +21.5% $119.32
2025-03-12 Raymond James Strong Buy $135 $97 -38 -30.2% $138.99
2024-10-15 KeyBanc Brett Fishbin Initiated $198 — +9.8% $180.30
2024-10-13 Jefferies Michael Toomey Initiated $183 — +2.4% $178.72
2024-06-16 Raymond James Jayson Bedford $190 $135 -55 +15.0% $117.44
2022-08-09 Raymond James — $208 $190 -18 +1.0% $188.10
2022-08-08 Raymond James — $235 $208 -27 +15.8% $179.63
2022-05-10 Raymond James — Initiated $235 — +16.8% $201.17

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
4
ROE
2
ROA
4
D/E
1
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ICUI receives an overall rating of B-. Strongest factors: DCF (4/5), ROA (4/5). Areas of concern: ROE (2/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-01 B B-
2026-08-04 B- B
2026-07-25 B B-
2026-07-22 B- B
2026-07-20 B B-
2026-07-16 B- B
2026-07-01 B+ B-
2026-06-16 B B+
2026-05-11 B- B
2026-05-08 B B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 52 Grade B
Profitability
22
Balance Sheet
52
Earnings Quality
80
Growth
48
Value
45
Momentum
80
Safety
50
Cash Flow
61
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ICUI scores highest in Earnings Quality (80/100) and lowest in Profitability (22/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.27
Grey Zone
Piotroski F-Score
6/9
✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✗
Beneish M-Score
-2.80
Unlikely Manipulator
Ohlson O-Score
-8.56
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB
Score: 41.0/100
Trend: Stable
Earnings Quality
75/100
OCF/NI: 7.86x
Accruals: -5.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ICUI scores 2.27, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ICUI scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ICUI's score of -2.80 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ICUI's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ICUI receives an estimated rating of BB (score: 41.0/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ICUI's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
132.82x
PEG
0.01x
P/S
1.84x
P/B
1.85x
P/FCF
24.02x
P/OCF
15.53x
EV/EBITDA
15.61x
EV/Revenue
2.15x
EV/EBIT
108.45x
EV/FCF
30.39x
Earnings Yield
0.82%
FCF Yield
4.16%
Shareholder Yield
0.24%
Graham Number
$48.19
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 132.8x earnings, ICUI is priced for high growth expectations. Graham's intrinsic value formula yields $48.19 per share, 231% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
-7.757
NI / EBT
×
Interest Burden
-0.091
EBT / EBIT
×
EBIT Margin
0.020
EBIT / Rev
×
Asset Turnover
0.535
Rev / Assets
×
Equity Multiplier
1.893
Assets / Equity
=
ROE
1.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ICUI's ROE of 1.4% is driven by Asset Turnover (0.535), indicating efficient use of assets to generate revenue. A tax burden ratio of -7.76 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$10.21
Price/Value
14.36x
Margin of Safety
-1335.53%
Premium
1335.53%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ICUI's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ICUI trades at a 1336% premium to its adjusted intrinsic value of $10.21, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 132.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$159.38
Median 1Y
$137.65
5th Pctile
$68.06
95th Pctile
$278.51
Ann. Volatility
41.7%
Analyst Target
$192.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Vivek Jain,
Chairman of the Board and Chief Executive Officer
$775,000 $4,500,023 $6,452,042
Christian Voigtlander, Operating
rating Officer
$500,000 $3,000,110 $3,950,110
Brian Bonnell, Financial
ancial Officer
$475,000 $3,000,110 $3,902,610
Virginia Sanzone, Corporate
Vice President, General Counsel
$430,000 $2,000,073 $2,817,073
Daniel Woolson, Corporate
Vice President, General Manager - Infusion Systems
$395,192 $1,350,135 $2,116,827

CEO Pay Ratio

134:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $6,452,042
Avg Employee Cost (SGA/emp): $48,093
Employees: 13,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
13,000
-13.3% YoY
Revenue / Employee
$171,540
Rev: $2,230,025,000
Profit / Employee
$56
NI: $732,000
SGA / Employee
$48,093
Avg labor cost proxy
R&D / Employee
$6,730
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 7.2% 6.6% 2.2% 0.3% -2.2% -4.0% -2.2% -2.3% -1.4% -1.4% -2.8% -3.4% -5.4% -5.8% -4.6% -1.8% -0.4% 0.0% 2.3% 1.4% 1.41%
ROA 6.1% 5.7% 1.3% 0.2% -1.2% -2.3% -1.0% -1.1% -0.6% -0.7% -1.4% -1.6% -2.6% -2.7% -2.2% -0.9% -0.2% 0.0% 1.1% 0.7% 0.74%
ROIC 9.7% 9.4% 1.5% 0.4% -0.4% -0.9% 0.2% 0.2% 0.8% 0.5% 0.1% 0.2% -0.2% 1.0% 1.6% -5.0% -0.6% 0.4% 12.4% 2.7% 2.75%
ROCE 7.9% 7.4% 1.3% 0.5% -0.5% -1.1% 0.2% 0.3% 0.6% 0.4% -0.1% -0.0% -0.1% 1.1% 1.8% 3.2% 3.4% 2.6% 1.7% 1.2% 1.23%
Gross Margin 38.0% 37.4% 31.1% 29.9% 31.2% 30.3% 33.8% 35.0% 33.2% 29.2% 32.7% 34.8% 34.8% 36.1% 34.7% 37.9% 37.4% 37.4% 32.6% 42.6% 42.61%
Operating Margin 11.4% 7.0% -7.8% -0.0% -0.1% -0.0% 1.7% 0.5% 4.1% -2.1% -1.9% 1.3% 1.4% 6.0% 2.1% 1.9% 2.6% 4.7% 5.8% 7.1% 7.09%
Net Margin 9.2% 5.9% -7.0% -1.3% -2.2% -2.7% -1.7% -1.8% 1.3% -2.9% -7.0% -3.6% -5.6% -3.8% -2.6% 6.4% -0.6% -2.9% 5.7% 3.5% 3.46%
EBITDA Margin 18.0% 13.8% 2.2% 11.8% 9.8% 9.5% 11.7% 11.0% 51.6% 8.0% 8.0% 10.5% 11.0% 13.9% 10.6% 19.4% 12.4% 11.3% 5.5% 25.6% 25.62%
FCF Margin 13.5% 15.1% 9.0% 0.9% -3.0% -6.8% -4.4% -1.6% -0.2% 3.4% 3.4% 6.9% 7.3% 5.2% 5.6% 2.6% 2.9% 4.0% 3.7% 7.1% 7.08%
OCF Margin 20.3% 20.3% 13.9% 5.5% 1.1% -2.7% -0.8% 1.8% 3.3% 7.4% 7.6% 11.0% 10.9% 8.6% 8.7% 5.9% 6.9% 8.1% 7.8% 10.9% 10.95%
ROE 3Y Avg snapshot only -1.27%
ROE 5Y Avg snapshot only -1.17%
ROA 3Y Avg snapshot only -0.60%
ROIC 3Y Avg snapshot only -0.43%
ROIC Economic snapshot only 2.54%
Cash ROA snapshot only 5.95%
Cash ROIC snapshot only 7.56%
CROIC snapshot only 4.89%
NOPAT Margin snapshot only 3.98%
Pretax Margin snapshot only -0.18%
R&D / Revenue snapshot only 4.00%
SGA / Revenue snapshot only 28.48%
SBC / Revenue snapshot only 1.90%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 46.38 50.18 127.36 718.97 -92.74 -50.85 -86.06 -88.47 -103.41 -81.19 -43.83 -40.92 -40.12 -32.29 -36.37 -88.37 -402.25 4811.60 70.18 122.02 132.817
P/S Ratio 3.91 3.93 3.42 2.21 1.76 1.66 1.72 1.87 1.29 1.07 1.15 1.26 1.90 1.60 1.41 1.38 1.28 1.58 1.51 1.70 1.845
P/B Ratio 3.19 3.20 2.42 1.88 1.79 1.81 1.89 2.03 1.38 1.13 1.26 1.42 2.17 1.93 1.71 1.54 1.39 1.66 1.54 1.71 1.852
P/FCF 28.97 26.01 37.98 245.88 -59.52 -24.44 -38.62 -117.49 -534.86 31.20 33.73 18.18 26.16 30.51 25.37 53.48 44.11 39.36 40.45 24.02 24.023
P/OCF 19.25 19.35 24.50 39.79 162.16 — — 106.27 39.61 14.49 15.22 11.40 17.46 18.63 16.26 23.52 18.57 19.58 19.42 15.53 15.533
EV/EBITDA 20.71 21.77 37.85 29.20 27.78 27.66 22.22 24.17 9.44 8.39 9.21 9.71 26.39 19.75 16.93 13.50 12.42 15.48 16.39 15.61 15.605
EV/Revenue 3.53 3.54 4.33 3.04 2.49 2.32 2.37 2.54 1.96 1.71 1.79 1.85 2.48 2.16 1.95 1.84 1.74 2.06 2.00 2.15 2.151
EV/EBIT 35.07 37.51 119.94 269.49 -279.91 -121.52 648.93 485.39 184.93 247.01 -718.80 -2909.01 -1505.60 126.67 72.33 37.92 33.20 49.37 74.39 108.45 108.451
EV/FCF 26.17 23.38 48.14 338.33 -84.17 -34.28 -53.33 -159.28 -814.46 49.97 52.36 26.82 34.06 41.22 35.12 71.33 59.97 51.47 53.55 30.39 30.392
Earnings Yield 2.2% 2.0% 0.8% 0.1% -1.1% -2.0% -1.2% -1.1% -1.0% -1.2% -2.3% -2.4% -2.5% -3.1% -2.7% -1.1% -0.2% 0.0% 1.4% 0.8% 0.82%
FCF Yield 3.5% 3.8% 2.6% 0.4% -1.7% -4.1% -2.6% -0.9% -0.2% 3.2% 3.0% 5.5% 3.8% 3.3% 3.9% 1.9% 2.3% 2.5% 2.5% 4.2% 4.16%
PEG Ratio snapshot only 0.006
Price/Tangible Book snapshot only 36.787
EV/OCF snapshot only 19.650
EV/Gross Profit snapshot only 5.726
Acquirers Multiple snapshot only 42.708
Shareholder Yield snapshot only 0.24%
Graham Number snapshot only $48.19
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 5.43 5.13 2.36 2.43 2.44 2.50 2.62 2.56 2.62 2.53 2.61 2.41 2.29 2.59 2.59 2.44 2.45 2.36 2.30 2.43 2.430
Quick Ratio 3.86 3.68 1.27 1.23 1.17 1.09 1.00 0.96 0.98 1.06 1.09 1.08 1.03 1.54 1.52 1.17 1.19 1.13 1.13 1.21 1.211
Debt/Equity 0.03 0.03 0.80 0.84 0.86 0.83 0.83 0.81 0.82 0.80 0.82 0.82 0.81 0.84 0.81 0.66 0.64 0.66 0.64 0.59 0.591
Net Debt/Equity -0.31 -0.32 0.65 0.71 0.74 0.73 0.72 0.72 0.72 0.68 0.69 0.68 0.66 0.68 0.66 0.52 0.50 0.51 0.50 0.45 0.452
Debt/Assets 0.03 0.02 0.37 0.38 0.39 0.38 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.39 0.38 0.34 0.33 0.34 0.33 0.32 0.320
Debt/EBITDA 0.21 0.21 9.94 9.43 9.48 9.05 7.04 7.16 3.67 3.71 3.85 3.81 7.55 6.31 5.74 4.31 4.21 4.68 5.11 4.27 4.272
Net Debt/EBITDA -2.22 -2.44 7.99 7.98 8.14 7.94 6.13 6.34 3.24 3.15 3.28 3.13 6.13 5.13 4.70 3.38 3.28 3.64 4.01 3.27 3.270
Interest Coverage 265.49 144.57 3.88 0.66 -0.35 -0.61 0.10 0.13 0.25 0.15 -0.05 -0.01 -0.04 0.38 0.60 1.09 1.24 0.96 0.66 0.52 0.516
Equity Multiplier 1.16 1.16 2.18 2.20 2.21 2.16 2.13 2.11 2.09 2.06 2.07 2.10 2.10 2.14 2.11 1.94 1.93 1.91 1.90 1.85 1.846
Cash Ratio snapshot only 0.599
Debt Service Coverage snapshot only 3.588
Cash to Debt snapshot only 0.235
FCF to Debt snapshot only 0.120
Defensive Interval snapshot only 268.6 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.73 0.72 0.47 0.56 0.65 0.71 0.50 0.51 0.51 0.51 0.52 0.53 0.54 0.56 0.57 0.57 0.55 0.54 0.53 0.53 0.535
Inventory Turnover 2.65 2.73 2.38 2.69 3.04 3.21 2.47 2.28 2.17 2.16 2.12 2.13 2.16 2.41 2.45 2.34 2.24 2.35 2.30 2.20 2.203
Receivables Turnover 9.24 11.45 9.54 10.57 12.42 13.92 13.47 12.13 12.01 11.79 15.86 14.68 13.94 13.83 15.31 14.32 12.70 12.28 11.59 11.90 11.896
Payables Turnover 11.36 10.78 7.25 8.75 10.43 10.65 8.18 8.39 8.50 8.30 8.99 9.65 9.89 10.45 9.44 9.39 8.66 9.32 7.74 8.48 8.480
DSO 40 32 38 35 29 26 27 30 30 31 23 25 26 26 24 25 29 30 31 31 30.7 days
DIO 138 134 154 135 120 114 148 160 168 169 173 171 169 152 149 156 163 155 159 166 165.7 days
DPO 32 34 50 42 35 34 45 43 43 44 41 38 37 35 39 39 42 39 47 43 43.0 days
Cash Conversion Cycle 145 132 142 128 115 106 130 147 155 156 155 158 158 143 134 142 149 146 143 153 153.3 days
Fixed Asset Turnover snapshot only 4.449
Operating Cycle snapshot only 196.4 days
Cash Velocity snapshot only 7.239
Capital Intensity snapshot only 1.839
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 2.4% 3.6% 22.3% 39.3% 57.6% 73.2% 49.6% 28.8% 10.1% -0.9% -2.1% 0.5% 4.0% 5.4% 7.2% 3.0% -0.8% -6.3% -10.9% -9.0% -8.98%
Net Income 34.4% 18.7% -55.9% -94.7% -1.4% -1.7% -2.1% -9.9% 27.8% 60.1% -28.9% -46.0% -3.0% -3.0% -58.0% 47.8% 93.4% 1.0% 1.5% 1.8% 1.81%
EPS 33.3% 17.7% -59.6% -95.2% -1.3% -1.7% -2.1% -9.8% 29.1% 60.3% -27.8% -44.1% -2.9% -2.9% -55.9% 48.5% 93.4% 1.0% 1.5% 1.8% 1.80%
FCF 70.9% 57.0% -7.6% -90.9% -1.3% -1.8% -1.7% -3.3% 91.0% 1.5% 1.8% 5.4% 32.4% 61.4% 74.3% -61.7% -60.6% -28.1% -40.2% 1.5% 1.50%
EBITDA 25.6% 14.2% -8.6% -9.5% -17.1% -10.4% 39.6% 30.0% 1.6% 1.4% 78.1% 83.0% -53.0% -43.4% -36.4% -26.7% 47.5% 14.5% -5.7% -7.7% -7.73%
Op. Income 42.1% 25.6% -44.8% -82.4% -1.1% -1.3% -84.1% -42.7% 2.8% 1.5% -67.9% -32.8% -1.2% 88.2% 23.0% 8.0% 11.8% 45.3% 20.6% 56.7% 56.70%
OCF Growth snapshot only 70.26%
Asset Growth snapshot only -3.31%
Equity Growth snapshot only 1.71%
Debt Growth snapshot only -8.53%
Shares Change snapshot only 1.36%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y -3.2% -2.0% 4.3% 10.8% 16.5% 21.7% 22.2% 22.3% 21.1% 21.1% 21.4% 21.7% 21.8% 21.9% 16.2% 10.0% 4.3% -0.7% -2.2% -2.0% -1.99%
Revenue 5Y 28.2% 28.3% 23.5% 18.2% 14.9% 12.0% 10.2% 9.7% 9.5% 10.0% 10.7% 11.9% 12.6% 13.5% 13.9% 13.6% 12.9% 11.9% 11.3% 11.0% 11.05%
EPS 3Y 8.2% 49.9% -11.8% -52.8% — — — — — — — — — — — — — — — — —
EPS 5Y 8.1% 5.7% -19.5% -37.4% — — — — — — — — — — — — — -62.5% -15.7% -24.1% -24.06%
Net Income 3Y 8.4% 53.0% -9.0% -51.1% — — — — — — — — — — — — — — — — —
Net Income 5Y 13.1% 10.3% -16.3% -35.0% — — — — — — — — — — — — — -61.5% -13.1% -21.9% -21.86%
EBITDA 3Y -13.3% -0.2% -6.3% -1.0% 0.4% -4.0% 8.7% 8.9% 38.5% 34.9% 31.5% 29.1% -0.2% 6.7% 16.5% 20.3% 20.9% 15.8% 2.2% 7.3% 7.34%
EBITDA 5Y 14.1% 12.6% 9.2% 23.7% 20.1% 1.8% 2.2% -5.3% 6.6% 16.4% 15.4% 18.2% 4.0% 3.7% 7.8% 11.6% 13.0% 9.7% 6.4% 7.8% 7.79%
Gross Profit 3Y -5.5% -4.8% -0.5% 5.2% 9.7% 13.9% 16.3% 17.4% 17.7% 17.0% 17.4% 16.8% 16.7% 18.8% 15.8% 12.8% 9.2% 5.6% 2.8% 2.8% 2.84%
Gross Profit 5Y 19.5% 19.5% 17.8% 16.2% 13.9% 10.4% 8.2% 6.3% 5.3% 5.4% 5.7% 8.0% 9.3% 11.8% 13.2% 13.1% 13.2% 12.2% 11.6% 11.5% 11.53%
Op. Income 3Y 18.9% 78.7% 3.6% -23.9% — — -56.2% -50.8% -26.9% -38.5% -69.6% -59.2% — -29.6% 6.9% 51.4% — — 1.1% 1.1% 1.12%
Op. Income 5Y 9.1% 8.2% 5.3% — — — 12.3% -30.5% -14.3% 1.1% -43.7% -29.8% — -16.7% -8.4% -6.3% -3.4% -8.7% -4.1% -0.9% -0.87%
FCF 3Y 24.8% 49.6% 34.5% 1.3% — — — — — -15.2% -19.9% -3.0% -0.9% -14.5% -1.0% 56.3% — — — — —
FCF 5Y 24.0% 24.9% — — — — — — — 5.4% 6.2% 1.6% 1.3% — 17.6% -2.9% -8.1% -6.7% -11.7% -2.7% -2.65%
OCF 3Y 10.6% 18.6% 10.3% -1.6% -40.0% — — -37.9% -27.6% -9.3% -10.0% -0.8% -1.1% -8.6% -0.8% 12.0% 92.9% — — 80.2% 80.24%
OCF 5Y 26.6% 24.4% — 38.6% -24.6% — — -30.1% -17.8% 0.7% 1.3% 19.7% 19.9% 14.9% 5.2% -3.8% -3.8% -4.2% -6.5% -1.9% -1.89%
Assets 3Y 6.0% 5.9% 43.3% 41.4% 39.5% 38.7% 35.0% 33.9% 36.3% 35.4% 34.4% 33.5% 32.8% 30.8% -4.1% -3.6% -2.7% -3.6% -3.5% -3.8% -3.82%
Assets 5Y 21.7% 21.7% 26.4% 25.3% 23.9% 24.7% 24.5% 23.9% 23.2% 22.5% 21.6% 21.4% 21.3% 20.0% 18.2% 17.2% 18.9% 18.1% 17.9% 17.1% 17.11%
Equity 3Y 8.1% 8.5% 19.3% 16.5% 14.5% 14.9% 15.1% 14.4% 13.1% 12.2% 10.8% 9.4% 8.8% 6.7% -3.0% 0.5% 1.9% 0.5% 0.2% 0.6% 0.58%
Book Value 3Y 7.9% 6.3% 15.7% 12.5% 10.5% 10.6% 11.0% 10.2% 8.5% 8.2% 6.8% 5.2% 4.6% 2.7% -4.2% -0.6% 0.8% -0.4% -1.4% -0.7% -0.73%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.55 0.59 0.76 0.82 0.66 0.42 0.43 0.51 0.57 0.58 0.70 0.81 0.83 0.79 0.87 0.90 0.84 0.65 0.57 0.57 0.569
Earnings Stability 0.60 0.39 0.00 0.03 0.07 0.16 0.13 0.51 0.54 0.33 0.68 0.67 0.75 0.78 0.93 0.76 0.51 0.41 0.23 0.19 0.187
Margin Stability 0.83 0.83 0.89 0.94 0.92 0.91 0.94 0.93 0.91 0.89 0.89 0.92 0.92 0.92 0.94 0.94 0.94 0.92 0.93 0.93 0.932
Rev. Growth Consistency 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
FCF Positive Streak 1 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1
Earnings Persistence 0.86 0.93 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.81 0.50 0.20 0.20 0.20 0.200
Earnings Smoothness 0.71 0.83 0.22 0.00 — — — — — — — — — — — — — — — — —
ROE Trend 0.01 -0.00 -0.04 -0.06 -0.08 -0.10 -0.06 -0.06 -0.04 -0.03 -0.03 -0.02 -0.04 -0.04 -0.02 0.01 0.03 0.04 0.06 0.04 0.040
Gross Margin Trend 0.00 0.01 -0.01 -0.03 -0.05 -0.06 -0.04 -0.02 -0.02 -0.01 -0.01 -0.00 0.00 0.03 0.03 0.03 0.04 0.03 0.03 0.03 0.034
FCF Margin Trend 0.09 0.10 0.01 -0.09 -0.14 -0.19 -0.15 -0.09 -0.06 -0.01 0.01 0.07 0.09 0.07 0.06 -0.00 -0.01 -0.00 -0.01 0.02 0.023
Sustainable Growth Rate 7.2% 6.6% 2.2% 0.3% — — — — — — — — — — — — — 0.0% 2.3% 1.4% 1.41%
Internal Growth Rate 6.5% 6.0% 1.3% 0.2% — — — — — — — — — — — — — 0.0% 1.1% 0.8% 0.75%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.41 2.59 5.20 18.07 -0.57 0.84 0.42 -0.83 -2.61 -5.60 -2.88 -3.59 -2.30 -1.73 -2.24 -3.76 -21.66 245.69 3.61 7.86 7.856
FCF/OCF 0.66 0.74 0.65 0.16 -2.72 2.49 5.25 -0.90 -0.07 0.46 0.45 0.63 0.67 0.61 0.64 0.44 0.42 0.50 0.48 0.65 0.647
FCF/Net Income snapshot only 5.079
OCF/EBITDA snapshot only 0.794
CapEx/Revenue 6.8% 5.2% 4.9% 4.6% 4.0% 4.1% 3.6% 3.4% 3.5% 3.9% 4.2% 4.1% 3.6% 3.3% 3.1% 3.3% 4.0% 4.1% 4.0% 3.9% 3.87%
CapEx/Depreciation snapshot only 0.328
Accruals Ratio -0.09 -0.09 -0.05 -0.03 -0.02 -0.00 -0.01 -0.02 -0.02 -0.04 -0.05 -0.07 -0.08 -0.07 -0.07 -0.04 -0.04 -0.04 -0.03 -0.05 -0.051
Sloan Accruals snapshot only -0.059
Cash Flow Adequacy snapshot only 2.829
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 0.4% 0.4% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.48 $0.47 $0.47 $0.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% — — — — — 14.9% 14.9% 7.2% 6.7% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 8.1% 20.2% 1.5% — — — — — — — — — — — — — 12.0% 1.0% 29.2% 29.24%
Div. Increase Streak — — — — — — — — — 0 0 0 0 — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.2% 0.2% 0.2% 0.2% 0.3% 0.5% 0.5% 0.7% 0.8% 0.4% 0.3% 0.2% 0.3% 0.4% 0.4% 0.4% 0.2% 1.5% 0.2% 0.24%
Net Buyback Yield -0.1% -0.0% 0.0% 0.0% 0.1% 0.2% 0.5% 0.4% 0.6% 0.7% 0.3% 0.2% 0.1% 0.0% 0.0% -0.1% 0.0% 0.1% 1.3% 0.2% 0.22%
Total Shareholder Return -0.1% -0.0% 0.0% 0.0% 0.1% 0.2% 0.5% 0.4% 0.6% 1.2% 0.7% 0.6% 0.3% 0.0% 0.0% -0.1% 0.0% 0.1% 1.3% 0.2% 0.22%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.84 0.84 1.00 -0.53 0.56 0.65 0.63 0.61 0.44 0.38 0.58 0.72 1.00 1.78 2.33 -2.32 -0.25 0.23 4.88 -7.76 -7.757
Interest Burden (EBT/EBIT) 0.99 0.99 0.74 -0.52 3.83 2.62 -8.66 -6.59 -2.64 -5.01 18.11 66.95 28.79 -1.63 -0.62 0.14 0.25 0.03 0.16 -0.09 -0.091
EBIT Margin 0.10 0.09 0.04 0.01 -0.01 -0.02 0.00 0.01 0.01 0.01 -0.00 -0.00 -0.00 0.02 0.03 0.05 0.05 0.04 0.03 0.02 0.020
Asset Turnover 0.73 0.72 0.47 0.56 0.65 0.71 0.50 0.51 0.51 0.51 0.52 0.53 0.54 0.56 0.57 0.57 0.55 0.54 0.53 0.53 0.535
Equity Multiplier 1.17 1.17 1.76 1.75 1.75 1.73 2.15 2.16 2.15 2.11 2.10 2.11 2.09 2.10 2.09 2.02 2.01 2.02 2.00 1.89 1.893
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $5.03 $4.73 $1.75 $0.23 $-1.62 $-3.10 $-1.92 $-2.01 $-1.15 $-1.23 $-2.45 $-2.90 $-4.54 $-4.81 $-3.82 $-1.50 $-0.30 $0.03 $1.84 $1.20 $1.20
Book Value/Share $73.17 $74.11 $92.15 $87.29 $84.19 $87.12 $87.47 $87.84 $86.11 $87.96 $85.37 $83.54 $83.83 $80.24 $81.00 $85.63 $86.17 $86.03 $83.87 $85.92 $86.07
Tangible Book/Share $62.79 $63.48 $-18.72 $-17.39 $-15.79 $-14.26 $-13.33 $-11.61 $-9.74 $-9.10 $-9.43 $-8.97 $-8.82 $-8.51 $-7.50 $-3.41 $-1.47 $-0.38 $1.09 $3.99 $3.99
Revenue/Share $59.65 $60.36 $65.19 $74.52 $85.43 $95.05 $96.01 $95.28 $92.30 $93.58 $93.19 $94.46 $95.76 $97.26 $98.62 $96.02 $94.00 $90.37 $85.64 $86.22 $86.37
FCF/Share $8.06 $9.13 $5.86 $0.67 $-2.53 $-6.44 $-4.27 $-1.52 $-0.22 $3.20 $3.18 $6.53 $6.97 $5.09 $5.47 $2.47 $2.72 $3.63 $3.19 $6.10 $6.11
OCF/Share $12.12 $12.27 $9.09 $4.13 $0.93 $-2.59 $-0.81 $1.68 $3.00 $6.88 $7.05 $10.42 $10.44 $8.33 $8.54 $5.62 $6.46 $7.29 $6.65 $9.44 $9.45
Cash/Share $24.74 $26.01 $14.56 $11.25 $10.32 $8.88 $9.34 $8.21 $8.17 $10.55 $10.38 $12.41 $12.79 $12.60 $11.81 $12.14 $12.14 $12.47 $11.45 $11.91 $11.93
EBITDA/Share $10.18 $9.80 $7.46 $7.75 $7.67 $7.99 $10.25 $10.00 $19.19 $19.04 $18.10 $18.05 $8.99 $10.62 $11.35 $13.06 $13.13 $12.05 $10.43 $11.88 $11.88
Debt/Share $2.16 $2.07 $74.12 $73.06 $72.70 $72.30 $72.18 $71.58 $70.38 $70.58 $69.66 $68.84 $67.89 $67.03 $65.22 $56.27 $55.28 $56.39 $53.26 $50.77 $50.77
Net Debt/Share $-22.58 $-23.95 $59.56 $61.81 $62.38 $63.42 $62.84 $63.37 $62.21 $60.03 $59.28 $56.44 $55.10 $54.43 $53.41 $44.12 $43.13 $43.92 $41.81 $38.86 $38.86
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.266
Altman Z-Prime snapshot only 3.976
Piotroski F-Score 7 8 3 3 2 2 4 5 6 5 2 3 5 5 5 7 7 6 5 6 6
Beneish M-Score -3.17 -2.92 -0.96 -0.72 -0.68 -0.54 -2.85 -2.90 -2.87 -2.93 -2.57 -2.89 -2.74 -2.87 -2.68 -2.31 -2.61 -2.80 -2.59 -2.80 -2.796
Ohlson O-Score snapshot only -8.555
ROIC (Greenblatt) snapshot only 3.58%
Net-Net WC snapshot only $-24.30
EVA snapshot only $-226595650.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB
Credit Score 94.13 93.84 45.84 28.76 25.93 32.22 34.64 35.67 33.26 34.72 33.43 33.71 36.67 38.89 40.31 40.48 41.27 39.04 39.05 40.96 40.957
Credit Grade snapshot only 12
Credit Trend snapshot only 0.476
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 22
Sector Credit Rank snapshot only 38

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms